Marshall Posner Selected Research

Marshall Posner Research Topics

Disease

18	Neoplasms (Cancer) 04/2021 - 06/2002
18	Squamous Cell Carcinoma of Head and Neck 01/2021 - 06/2002
13	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016 - 01/2004
8	Oropharyngeal Neoplasms 10/2019 - 07/2014
4	Mucositis 01/2019 - 12/2003
4	Carcinoma (Carcinomatosis) 08/2016 - 10/2003
2	Inflammation (Inflammations) 10/2018 - 01/2014
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2018 - 04/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2015 - 01/2012
2	Febrile Neutropenia 09/2014 - 03/2013
2	Xerostomia 10/2009 - 07/2007
2	Infections 11/2004 - 04/2004
1	Fatigue 10/2018
1	Melanoma (Melanoma, Malignant) 10/2018
1	Overweight 01/2018
1	Hyperuricemia 01/2017
1	Fever (Fevers) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Extranodal Extension 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Margins of Excision 01/2016
1	Disease Progression 06/2015
1	Neutropenia 09/2014
1	Marijuana Use 01/2014
1	Carcinogenesis 01/2014
1	Tongue Neoplasms (Tongue Neoplasm) 01/2014
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 07/2013
1	Second Primary Neoplasms (Neoplasms, Second) 01/2013
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2013
1	Residual Neoplasm 11/2010
1	Stomatitis 10/2009
1	Nasopharyngeal Carcinoma 03/2009
1	Epstein-Barr Virus Infections 03/2009
1	Neoplasm Metastasis (Metastasis) 06/2008
1	Pathologic Complete Response 06/2006

Drug/Important Bio-Agent (IBA)

8	Docetaxel (Taxotere)FDA Link 01/2019 - 01/2003
6	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 01/2003
6	Cisplatin (Platino)FDA LinkGeneric 09/2014 - 01/2003
4	AntibodiesIBA 10/2017 - 04/2004
4	Carboplatin (JM8)FDA LinkGeneric 09/2014 - 03/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 03/2003
3	Biomarkers (Surrogate Marker)IBA 10/2019 - 06/2015
3	AntigensIBA 11/2018 - 07/2015
3	Biological ProductsIBA 08/2015 - 11/2013
3	CytokinesIBA 01/2014 - 03/2009
2	RNA (Ribonucleic Acid)IBA 04/2021 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2004
2	EpitopesIBA 11/2018 - 11/2004
2	ChemokinesIBA 10/2018 - 01/2014
2	Amifostine (Ethyol)FDA LinkGeneric 10/2009 - 12/2003
2	Trastuzumab (Herceptin)FDA Link 02/2004 - 10/2003
1	Viral AntigensIBA 04/2021
1	AfatinibIBA 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2018
1	poly ICLCIBA 10/2018
1	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2018
1	Poly I-CIBA 10/2018
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 10/2018
1	Lysine (L-Lysine)FDA Link 10/2018
1	LigandsIBA 10/2018
1	Immunoglobulin G (IgG)IBA 10/2017
1	cabazitaxel FDA Link 01/2017
1	PlatinumIBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	Gemcitabine FDA Link 09/2014
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 09/2014
1	Antineoplastic Agents (Antineoplastics)IBA 05/2014
1	Taxoids (Taxanes)IBA 05/2014
1	CannabinoidsIBA 01/2014
1	Anticarcinogenic AgentsIBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Panitumumab (Vectibix)FDA Link 11/2013
1	vandetanib (ZD6474)IBA 08/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013
1	liposomal doxorubicin (Doxil)FDA Link 01/2012
1	Growth Factor ReceptorsIBA 11/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009
1	InterleukinsIBA 10/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2009
1	Peptides (Polypeptides)IBA 03/2009
1	cevimeline (Evoxac)FDA Link 07/2007
1	ErbB Receptors (EGF Receptor)IBA 09/2006
1	Cetuximab (Erbitux)FDA Link 09/2006
1	mannuronic acidIBA 11/2004

Therapy/Procedure

12	Therapeutics 01/2021 - 04/2004
12	Radiotherapy 01/2019 - 09/2006
7	Induction Chemotherapy 06/2014 - 01/2003
7	Chemoradiotherapy 06/2014 - 12/2003
3	Drug Therapy (Chemotherapy) 08/2008 - 04/2004
2	Immunotherapy 11/2018 - 11/2010
2	Enteral Nutrition (Feeding, Tube) 01/2018 - 12/2003
2	Aftercare (After-Treatment) 01/2017 - 07/2014
2	Adjuvant Chemoradiotherapy 08/2016 - 01/2016
2	Combined Modality Therapy 06/2008 - 08/2007
1	Gastrostomy 01/2016
1	Tonsillectomy 07/2015
1	Molecular Targeted Therapy 11/2010
1	Oral Administration 07/2007